Insights Into Chikungunya Virus Seropositivity and Clinical Manifestations During the 2024 Upsurge: A Study From Central India
Vishal Shete, Meena Mishra, Omna Nelumbium, Rashmi Mudliar, Bharatsing D Rathod, Nishaant Ramasamy, Preeti A Shahu, Shailendra Parihar · 2026
Read Insights Into Chikungunya Virus Seropositivity and Clinical Manifestations During the 2024 Upsurge: A Study From Central India by Vishal Shete, Meena Mishra, Omna Nelumbium, Rashmi Mudliar, Bharatsing D Rathod, Nishaant Ramasamy, Preeti A Shahu, Shailendra Parihar (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13632943.txt.
Description
Vishal Shete and co-authors describe chikungunya cases during the 2024 upsurge in central India in a 2026 study. The mosquito borne virus keeps returning in India with fever and joint pain. Records covered patients with acute fever who tested positive on an antibody test during 2024.
Of 943 people tested, 117, or 12.4 percent, were positive. Most were adults aged 19 to 49 and city residents. Joint pain was the top symptom, hitting large joints more than small ones, and rash appeared in about a quarter. Complications arose in 43.6 percent, most often joint pain that lingered past three months.
Catalog record
| CREATOR | Vishal Shete, Meena Mishra, Omna Nelumbium, Rashmi Mudliar, Bharatsing D Rathod, Nishaant Ramasamy, Preeti A Shahu, Shailendra Parihar |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |